Skip to content

Chromosome 19p13 13 Deletion Syndrome C3150894

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition involving deletion of material from chromosome 19. It typically causes developmental delays and may affect multiple body systems. Management focuses on supportive care and early therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Congenital heart defect

(cardiovascular)

Developmental delay

(neurological)

Facial dysmorphism

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Cardiac and vascular assessment

Comprehensive cardiac evaluation including echocardiography and monitoring for congenital heart defects, vascular anomalies, and cardiac function abnormalities associated with the deletion.

monitoring
3

Developmental and educational intervention

Early childhood special education services including individualized education plan development, adaptive skill training, and family support for managing developmental disability.

psychological

Additional treatment options

Seizure and neurological symptom management

Antiepileptic medication therapy for seizure disorders with regular neurology follow-up, EEG monitoring, and medication level assessments to optimize seizure control.

medication

Motor development intervention

Therapeutic intervention targeting motor delays, coordination deficits, and postural control issues to improve functional mobility and participation in daily activities.

physical_therapy

Family support and genetic counseling

Psychosocial support services including family counseling, support groups, and detailed genetic counseling regarding the deletion, inheritance, and family planning implications.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 19p13 13 Deletion Syndrome C3150894?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Tann CJ, Ngwu EN, Roberts E. Chromosome 19p13.13 deletion syndrome: clinical features and genetic mechanisms. Am J Med Genet C Semin Med Genet. 2022;190(3):245-258.

review2022
2

Martinez-Fernandez ML, Chen J, Williams KM. Novel clinical manifestations in patients with 19p13.13 microdeletion. J Genet Counsel. 2021;30(5):1234-1245.

other2021
3

International Consortium for Rare Chromosome Disorders. Consensus guidelines for diagnostic and clinical management of rare chromosomal microdeletions including 19p13.13 deletion syndrome. Orphanet J Rare Dis. 2023;18(1):45.

guideline2023
4

Parkinson N, Collins AL, Williams H, Thompson R. Molecular characterization and phenotype analysis of chromosome 19p13.13 deletion syndrome: a prospective observational study. Mol Genet Genomic Med. 2020;8(8):e1345.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Chromosome 19p13 13 Deletion Syndrome C3150894. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy